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Abstract
Background: Most comparisons between robot‐assisted partial nephrectomy
(RAPN) and open partial nephrectomy (OPN) indicate the superiority of RAPN, but
the learning curve is often not considered.
Methods: All consecutive partial nephrectomies from the very first RAPN at a single
tertiary referral centre (n ¼ 818, 500 RAPN vs. 313 OPN) were retrospectively
analyzed. Complications, success rates and surgical outcomes were compared. In-
equalities between cohorts and the inherent learning curve were controlled by
subgroup comparisons, regression analyses, and propensity score matching.
Results: Overall, RAPN had fewer complications, less blood loss, and shorter length
of stay. However, an inherent learning curve caused higher complications for the
first 4 years. Thereafter, perioperative outcomes clearly favoured RAPN, even for
more complex tumours.
Conclusions: In one of the largest monocentric cohorts over more than 10 years,
RAPN was found to be superior to OPN. However, not all advantages of RAPN are
immediate because a learning curve must be passed.
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1 | INTRODUCTION
Renal cell carcinoma (RCC) is the third most common malignancy of
the urinary tract. Its incidence has increased in recent years due to
improved imaging modalities and their wide application.1 Although
new therapeutic approaches have been developed, surgical removal
of the tumor remains the gold standard of treatment.2
In this context, partial nephrectomy (PN) has proven to be
oncologically equal to radical nephrectomy for small renal masses
and locally advanced tumours.3 Since the first laparoscopic partial
nephrectomy (LPN) in 1993 and the first robot‐assisted partial ne-
phrectomy (RAPN) in 2004, the standard approach for PN has been a
matter of debate.4,5 Due to a shorter and steeper learning curve,
RAPN was established much faster in urologic surgery.6 However,
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LPN also provides excellent results, even in complex and atypical
situations. A lower morbidity of LPN compared to open partial ne-
phrectomy (OPN) has been demonstrated with equal oncological
outcomes.7–9 Nevertheless, OPN is still considered the gold standard
according to the current guidelines.10,11
To date, many studies have compared surgical outcomes of OPN
with RAPN. RAPN has shown to be advantageous in terms of com-
plications, estimated blood loss (EBL), and length of hospital stay, but
it has a longer operating time and warm ischaemia time (WIT) in
many cases.12 Nonetheless, most studies cover shorter time spans,13
include limited patient numbers,14 or can only provide large patient
cohorts in multicenter settings.15 As the effect of inherent learning is
often not considered, it is difficult to draw direct conclusions for daily
urologic practice in a ‘real‐world’ setting. In addition, data are scarce
regarding the question of how much time is needed to reach better
outcomes with RAPN.
For this reason, we analyzed a large, single‐center cohort of 813
PNs, including 500 RAPNs and 313 OPNs, over a time span of more
than 10 years from 2007 to 2018. To show the impact of the inherent
learning curve of RAPN on surgical outcomes, all consecutive partial
nephrectomies from the very first RAPN in our department were
included. As patients were not randomized but rather assigned to
groups according to the surgeon's expertise, a regression analysis and
propensity score matching were performed to outweigh selection
bias.
2 | MATERIALS AND METHODS
All OPN and RAPN, including the very first case, at a tertiary referral
center from 2007 to 2018 were retrospectively included. The oper-
ative standard for OPN was a retroperitoneal approach. However,
four patients had anatomical abnormalities, such as a horseshoe
kidney, for which a transperitoneal approach had to be chosen. All
RAPNs were performed via a transperitoneal approach using a
DaVinci® Si or S system (Intuitive Surgical). To preserve the
maximum amount of nephron mass without impairing the oncological
outcome, the tumors were enucleated, if possible, otherwise they
were enucleoresected.16 All RAPNs were performed by seven trained
robotic surgeons with experience in at least 50–100 radical prosta-
tectomies, nephrectomies and pyeloplasties.
Patient age, gender, body mass index (BMI), ASA (American So-
ciety of Anaesthesiologists) score and number of prior abdominal
surgeries were obtained. Tumor laterality, size, growth pattern (endo‐
vs. exophytic), complexity and preoperative aspects and dimensions
used for an anatomical (PADUA) score served as tumor characteris-
tics.17 Surgical results included operating time, EBL, frequency and
duration of WIT, and postoperative complications according to Clavien
Dindo within 30 days after surgery. Final pathologic results with
positive surgical margins (PSMs) were reviewed. The Trifecta rate was
defined as absence of PSMs, WIT ≤ 25 min, and absence of any post-
operative complications. The margin, ischaemia and complications
(MIC) rate was defined as absence of PSMs, WIT ≤ 20 min, and absence
of major postoperative complications ≥ Clavien Dindo grade 3.6,18
As the primary outcome, complication and success rates (Trifecta
and MIC) were analyzed. Comparison of operating time, EBL, WIT,
off‐clamp excisions, PSMs, transfusion rates and length of stay
served as secondary outcomes.
OPN and RAPN cohorts were compared, including all cases over
the whole period and as time‐dependent subgroup analyses from
2007 to 2012 and 2013 to 2018. To analyze whether results changed
over time within groups, OPN cases from 2007 to 2012 were
compared with OPN cases from 2013 to 2018, likewise for RAPN.
The time when the overall complication rate per year of OPN
exceeded RAPN was estimated via a linear regression analysis.
Further uni‐ and multi‐variate regression analyses were conducted to
compare the influences of the surgical approach, PADUA score, and
patient‐specific characteristics on primary outcomes. A propensity
score matching for PADUA score, tumour size and number of prior
abdominal surgeries with a tolerance rate of 0.05 rendered a com-
parison of matched OPN and RAPN cohorts possible.
Demographic and perioperative data were analyzed with
descriptive statistics. Categorical variables were reported as fre-
quencies and proportions, and continuous data were reported as the
median and range. Fisher's exact and Mann–Whitney U‐tests were
used to compare between independent groups, McNemar and Wil-
coxon ranksum tests for dependent samples, and propensity score for
matched data. Covariates were included in the multiple regression
analysis only if the respective effect was significant in the univariate
analysis. Statistical analyses were performed with SPSS version 25
(IBM). All tests were two‐sided, and p‐values <0.05 were considered
significant. This study was approved by the Ethical Review Board of
Saarland (reference Bu 67/19), and all patients provided written
consent.
3 | RESULTS
3.1 | Overall comparison
A total of 813 partial nephrectomies were included from 2007 to
2018, with 500 RAPN and 313 OPN. The annual total caseload
increased from 42 in 2008 to 118 in 2017, mostly because RAPNs
were increasingly performed, from 4 procedures in 2008 to 88 in
2017 (see Figure 1).
Overall, patient demographics only differed regarding the num-
ber of prior abdominal surgeries (OPN > RAPN, p < 0.001; see
Table 1). As for tumor characteristics, tumours for OPN were larger
(4.2 vs. 3 cm, p < 0.001) and more complex: 60.9% of all tumours for
OPN, but only 33.7% for RAPN, were considered as high‐risk
(PADUA ≥ 10; p < 0.001).
Concerning primary outcomes, RAPN had fewer postoperative
complications, with 20% minor and 4.4% major complications (p <
0.001; see Table 1). Trifecta fulfilment was not different between
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OPN and RAPN, whereas MIC was fulfilled more often with OPN
(70.6% vs. 63%, p < 0.05).
As for secondary outcomes, EBL was lower in RAPN (200 vs. 300
ml, p < 0.001), and operating time was significantly longer (157 vs.
188 min, p < 0.001). The rate of off‐clamp excisions did not differ, but
WIT was significantly longer for RAPN (15 vs. 13 min, p < 0.01), and
6%–7% of cases had PSMs. Patients were discharged earlier after
RAPN (6 vs. 10 days, p < 0.001) with lower yet not significantly
different transfusion rates (8.8% vs. 12.8%).
3.2 | Propensity score matched analysis
By propensity score matching for the number of prior abdominal
surgeries, tumor size and PADUA score, 216 OPNs were matched with
216 RAPNs in a 1:1 fashion. The mean tumour size was 4 cm, and the
PADUA score was 10, with 56.5% (OPN) and 52.3% (RAPN) high‐risk
tumours (see Table S1). With regard to the overall comparison, dif-
ferences in EBL were no longer significant after propensity score
matching (OPN 300 vs. RAPN 250 ml), and all other primary and
secondary outcomes remained unchanged (see Table S1).
3.3 | Regression analysis
In the multivariate regression analysis, the surgical approach had a
significant impact on complications in favour of RAPN (see Table 2).
Higher patient age, ASA score and number of prior abdominal sur-
geries also increased the risk for complications (for all OR 1.03–1.48,
p < 0.05). The PADUA score did not have any impact on
complications.
Concerning success rates, the MIC rate was impacted by the
surgical approach, and RAPN had a lower odds ratio for fulfilling MIC
(0.61, p < 0.01). Higher PADUA scores had a negative impact on MIC
rates (OR 0.9, p < 0.05). As patient‐related factors, ASA, BMI and the
number of prior abdominal surgeries had a significant effect on
Trifecta or MIC fulfilment, regardless of the surgical approach (OR
0.71–0.97, p < 0.05, see Table 2).
3.4 | Inherent learning curve
Patient demographics did not change over time when comparing
cases from 2007 to 2012 with 2013 to 2018 only within RAPN and
only within OPN groups (see Table S2). Tumor size increased from
3.9 to 4.3 cm for OPN (p < 0.01). PADUA score did not change for
RAPN, but more mid‐ (34.2% vs. 21%) and high‐risk tumours (34.5%
vs. 17.5%) were treated (p < 0.01).
While the surgical outcomes remained unchanged for OPN,
operating time significantly decreased for RAPN (172 vs. 152 min,
p < 0.001). More tumors were excised off‐clamp in 2013–2018 (8.4%
vs. 17.9%, p < 0.01). WIT decreased by 5 min (p < 0.001), and patients
were discharged 1 day earlier (p < 0.001) with higher MIC rates (54%
vs. 66.4%, p < 0.05; see Table S2).
3.5 | Time‐dependent comparison
When comparing RAPN versus OPN from 2007 to 2012 and 2013 to
2018, the PADUA score and tumor size significantly differed within
both periods (p < 0.001). The number of prior abdominal surgeries
was higher in OPN from 2013 to 2018 (p < 0.001).
Concerning primary outcomes, RAPN was not superior in terms
of complication rates from 2007 to 2012, but it was superior from
2013 to 2018 (p < 0.001; see Table 3). When stratifying by year of
surgery, the overall complication rate significantly decreased from
50% in 2008 to 20.5% in 2017 for RAPN (p < 0.01), and it did not
significantly increase from 28.9% to 46.7% for OPN, respectively (see
Figure 2). A linear regression model indicated that the annual
complication rate for RAPN (Spearman's rho   0.73, p < 0.05) fell
below the corresponding complication rate for OPN in 2010 (rho
0.43; n.s.). While MIC was reached significantly more often from
2007 to 2012 with OPN (69% vs. 54.5%, p < 0.05), the success rates
were no longer different afterwards (see Table 3).
As for secondary outcomes, the operating time was shorter for
OPN (p < 0.001). Although EBL was already lower with RAPN from
2007 to 2012, this difference became significant in 2013–2018 (200
vs. 300 ml, p < 0.001). Correspondingly, blood transfusions were less
frequent with RAPN than OPN (p < 0.05). The number of off‐clamp
excisions and WIT were no longer different from 2013 to 2018.
Patients were always discharged earlier after RAPN (p < 0.001).
4 | DISCUSSION
In this study, a longitudinal, single‐center comparison of 500 robot‐
assisted versus 313 open partial nephrectomies from 2007 to 2018
was conducted. Of note, we included the very first RAPN at our
F I GUR E 1 Annual caseload of open (grey area) and robot‐
assisted partial nephrectomies (dotted area) from 2008 to 2017,
including the annual number of cases per group. OPN, open partial
nephrectomy; RAPN, robot‐assisted partial nephrectomy
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department and, from then on, all consecutive OPN and RAPN over
more than 10 years. The annual caseload of PNs considerably
increased from 42 in 2008 to 118 in 2017 (see Figure 1). This can be
mainly attributed to an increase of RAPN, reflecting higher accep-
tance of robotic kidney surgery, not only in our department but also
in urology in general, within the last years.19 On the other hand, the
OPN caseload remained constant, highlighting its continued impor-
tance for selected indications, such as to avoid otherwise unnec-
essary, minimally invasive nephrectomies.11
As a primary outcome, we compared the complication rates of
OPN with RAPN (see Table 1). In accordance with Ficarra et al. and
Porpiglia et al., the postoperative complication rates were signifi-
cantly higher after OPN.13,20 Consequently, the surgical approach
showed to have a significant impact on complication rates in the
multivariate regression analysis: the risk was lowered by 34% for
minor and up to 64% for major complications for the robotic
approach (see Table 2). Likewise, Peyronnet et al. found the risk of
postoperative complications to be 2.2 times higher in OPN.15 In
addition, patient‐specific factors (higher patient age or ASA score)
were predictive for complications. In contrast to other publications,
prior abdominal surgery proved to have a significant impact (OR 1.2,
p < 0.01).21 Nonetheless, prior abdominal surgery is not
TAB L E 1 Overall comparison of
patient demographics, tumor
characteristics and surgical outcomes of
313 OPN and 500 RAPN
OPN RPN p‐value
Patient demographics
Age (year) 65 (21; 88) 63 (24; 93) n.s.
Gender male 194 (62%) 327 (65.4%) n.s
BMI (kg/m2) 26.9 (17.1; 50.1) 27.6 (18; 59.5) n.s
ASA 2 (1; 4) 2 (1; 4) n.s
Prior abdominal surgeries 1 (0; 13) 1 (0; 5) <0.001
Tumour characteristics
Side left 172 (55%) 247 (49.4%) n.s.
Size (cm) 4.2 (1; 20.4) 3 (0.4; 10) <0.001
Exophytic tumour 24 (9.49%) 35 (7.94%) n.s.
PADUA score 10 (6; 13) 8 (6; 14) <0.001
Low‐risk (6, 7) 34 (13.4%) 139 (31.7%)
Mid‐risk (8, 9) 65 (25.7%) 152 (34.6%)
High‐risk (≥10) 154 (60.9%) 148 (33.7%)
Primary outcome
Complications <0.001
Any 110 (35.2%) 122 (24.4%)
Minor 72 (23%) 100 (20%)
Major 38 (12.2%) 22 (4.4%)
Trifecta 182 (58.1%) 294 (58.8%) n.s.
MIC 221 (70.6%) 315 (63.0%) <0.05
Secondary outcome
Operating time (min) 118 (44; 280) 157 (52; 376) <0.001
Blood loss (ml) 300 (10; 2600) 200 (0; 2600) <0.001
WIT (min) 13 (0; 38) 15 (0; 43) <0.01
Off‐clamp excisions 60 (19.2%) 76 (15.6%) n.s.
PSM 22 (7.2%) 32 (6.4%) n.s.
Transfusion rate 40 (12.78%) 44 (8.8%) n.s.
Length of stay (day) 10 (4; 56) 6 (3; 49) <0.001
Note: Values in bold are statistically significant and have a p‐value < 0.05.
Abbreviations: ASA, American Society of Anaesthesiologists; BMI, body mass index; MIC, margin
ischaemia complications; OPN, open partial nephrectomy; PN, partial nephrectomy; PSM, positive
surgical margin; RAPN, robot‐assisted partial nephrectomy; WIT, warm ischemia time.
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contraindicative for minimally invasive kidney surgery at our
department. We did not conduct retroperitoneoscopic PN, which
potentially could reduce the risk of complications caused by prior
abdominal surgery.22 In contrast, the PADUA score, and therefore
tumor complexity, did not impact complication rates in the regression
analysis (see Table 2).
It has also been a major objective to improve ‘success rates’ in
PN in recent years, and Trifecta and MIC rate are two ways of
measuring this.6,18 When comparing RAPN and OPN cohorts overall,
the Trifecta rates did not differ (see Table 1). However, the MIC rates
were higher for OPN than RAPN (70.6% vs. 63.0% p < 0.05). As the
PSM rates did not differ, and complication rates were much higher
for OPN, the difference in MIC fulfilment resulted mainly from a
longer WIT for RAPN (15 vs. 13 min, p < 0.01). A longer WIT in RAPN
has also been described elsewhere.13,23 Most likely, a difference of 2
min in WIT will not have any effect on postoperative renal function,
as long as the WIT is no longer than 20–25 min.24 Recently, it has
clearly been shown that preoperative renal function and the amount
of preserved renal parenchyma are more important predictors of
postoperative renal function.25 Correspondingly, Takagi et al.
compared OPN versus RAPN only in patients with chronic kidney
disease and found no difference in outcomes.26 However, other
groups also described higher Trifecta and MIC rates and shorter WIT
in RAPN.15,20
When comparing both groups overall, patient demographics and
tumor characteristics differed in three aspects: tumour size (Δ1.2
cm), PADUA score (8 vs. 10), and the number of prior abdominal
surgeries (for all p < 0.001). For this reason, we performed a 1:1
propensity score matching and matched a total of 432 patients as
case controls (see Table S1). It is important to highlight that more
than 50% of patients had high‐risk tumors, with a PADUA score ≥10,
within this matched cohort. Regardless, neither primary nor sec-
ondary outcomes changed in comparison with the overall compari-
son. Only blood loss was no longer statistically significant between
OPN and RAPN after propensity score matching, and it remained
slightly lower for RAPN (250 vs. 300 ml, see Table S1).27 Operating
time and WIT were longer for RAPN, which is in line with other
studies.23,28 RAPN still had fewer postoperative complications than
OPN (p < 0.001), which has been published for (highly) complex le-
sions.29,30 Similarly, Harke et al. compared completely endophytic,
and therefore complex, tumors and found higher Trifecta rates for
RAPN than OPN (75% vs. 68%, n.s.).31 The length of hospital stay was
shorter for RAPN as well (6 vs. 10 days, p < 0.001, see Table S1).
However, others report even shorter length of stays for RAPN
ranging from 3 to 5 days.15,30 This can be attributed to differences in
national health care systems, as German reimbursement covers a
longer hospital stay.32–34 In fact, patients could have been discharged
earlier from a surgical point of view, but it has not been a crucial
parameter for us, either for RAPN or OPN.
We suspected that an inherent learning curve in the RAPN
cohort might affect the surgical results. Learning curves of robotic
surgeons have shown to be steeper than in laparoscopy and do not
level out until 300 RAPN cases.35,36 For this reason, we conducted a
time‐dependent subgroup analysis by comparing cases from 2007 to
2012 with 2013 to 2018 only within RAPN and OPN groups (see
Table S2). In both cohorts, solely the tumor characteristics changed
minimally over time. In contrast to OPN, where the surgical results
remained stable, RAPN clearly showed an inherent learning curve:
MIC rates increased (54.5%–66.4%) while operating time (172–152
min), WIT (18–13 min), and length of stay (7–6 days) further
decreased (for all p < 0.05). At the same time, tumors became more
complex, and mid‐ and high‐risk tumors were operated on to a
greater extent (see Table S2).37
To assess the impact of the inherent learning curve in RAPN
compared with OPN, we compared cases from 2007 to 2012 and
from 2013 to 2018 between the groups (see Table 3). It was not
surprising that RAPN did not reach lower postoperative complication
rates than OPN from 2007 to 2012. Larcher et al. recently illustrated
a learning curve for a complication‐free course as a function of the
robotic surgeon's experience.36 They showed that increasing expe-
rience lowered the risk of complications in RAPN. In line with these
results, the annual complication rate of RAPN fell below that of OPN
in 2010 in our cohort (see Figure 2). Although the tumors in the
RAPN group were significantly more complex (see Table S2),
increasing experience made lower overall complication rates possible
four years after the initiation of a robotic program at our institute.
Accordingly, the MIC rates were no longer superior for OPN, and the
TAB L E 2 Multivariate logistic regression model of
complications and Trifecta/MIC fulfilment, only significant
associations are shown
Variable OR (95% CI) p‐value
Any complication
OPN versus RAPN 0.66 (0.48; 0.92) <0.05
ASA 1.48 (1.31; 1.93) <0.01
Prior abdominal surgery 1.21 (1.06; 1.38) <0.01
Minor complications
ASA 1.35 (1.00; 1.80) <0.05
Prior abdominal surgery 1.25 (1.09; 1.43) <0.001
Major complications
OPN versus RAPN 0.34 (0.2; 0.59) <0.001
Age 1.03 (1.01; 1.06) <0.05
Trifecta
ASA 0.74 (0.56; 0.94) <0.05
Prior abdominal surgery 0.76 (0.66; 0.86) <0.001
MIC
OPN versus RAPN 0.61 (0.43; 0.87) <0.01
PADUA score 0.92 (0.75; 0.91) <0.001
BMI 0.97 (0.93; 0.99) <0.05
Abbreviations: ASA, American Society of Anaesthesiologists; BMI, body
mass index; MIC, margin ischemia complications; OPN, open partial
nephrectomy; RAPN, robot‐assisted partial nephrectomy.
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differences in WIT were no longer significant from 2013 to 2018. In
addition, blood loss and transfusion rates became significantly
different in favor of RAPN (p < 0.05).
Therefore, we conclude that RAPN is not better than OPN per
se, because good results rely on experience that needs to be gained
beforehand. Correspondingly, the current European guidelines on
RCC state that the choice of surgical approach should be ‘based on
surgeon's expertize and skills’.11 However, RAPN is not superior to
OPN in all terms. Although the difference in operating times
decreased from 57.5 to 32 min, OPN was still the significantly shorter
approach, even from 2013 to 2018 (p < 0.001).
This study is not devoid of limitations. Due to its retrospective
nature, cohorts were not perfectly balanced in terms of caseload,
patient, and tumor characteristics. Regression analysis and pro-
pensity score matching are appropriate methods to reduce imbal-
ance, but they cannot replace randomized study designs. For
this reason, the OpeRa study (Open vs. robotic assisted PN,
NCT03849820) has started enrolling patients in a prospective,
randomized fashion. Furthermore, we could not fully control for the
impact of the inherent learning curve of RAPN in pairwise com-
parisons, as there were no obvious learning effects for OPN. In fact,
the learning curve for OPN had been passed much earlier because
the experience of the senior staff with OPN reached back more
than 30 years.38
In summary, we analyzed one of the largest monocentric cohorts
so far comparing OPN with RAPN. We conclude that RAPN is clearly
superior to OPN in terms of the perioperative results. Nonetheless,
not all advantages of robotic surgery can be reached immediately
when establishing a robotic partial nephrectomy program, as a
learning curve must be passed.
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TAB L E 3 Time‐dependent subgroup analysis of OPN versus RAPN only in 2007–2012 and 2013–2018
2007–2012 2013–2018
OPN (n ¼ 155) RAPN (n ¼ 143) p‐value OPN (n ¼ 158) RAPN (n ¼ 357) p‐value
Primary outcome
Complications n.s. <0.001
Any 43 (32.3%) 43 (30.1%) 60 (37.9%) 79 (22.1%)
Minor 31 (20%) 36 (15.1%) 41 (25.9%) 64 (17.8%)
Major 19 (12.3%) 7 (15%) 19 (12%) 15 (4.2%)
Trifecta 91 (58.7%) 77 (53.8%) n.s. 91 (57.6%) 217 (60.8%) n.s.
MIC 107 (69%) 78 (54.5%) <0.05 114 (72.2%) 237 (66.4%) n.s.
Secondary outcome
Operating time 114.5 (48;246) 172 (68; 356) <0.001 120 (44; 280) 152 (52; 376) <0.001
Blood loss 300 (10; 2100) 220 (20; 2000) n.s. 300 (20; 2600) 200 (0; 2600) <0.001
WIT 12 (0; 37) 18 (0; 43) <0.001 13 (0; 38) 13 (0; 40) n.s.
Off‐clamp 30 (19.4%) 12 (8.6%) <0.01 30 (19%) 64 (18.4%) n.s.
PSM 14 (9%) 9 (6.5%) n.s. 8 (5%) 23 (7.3%) n.s.
Transfusion rate 19 (12.3%) 18 (12.6%) n.s. 21 (13.3%) 26 (7.3%) <0.05
Length of stay 9 (5; 56) 7 (4; 29) <0.001 10 (4; 42) 6 (3; 49) <0.001
Note: Values in bold are statistically significant and have a p‐value < 0.05.
Abbreviations: ASA, American Society of Anaesthesiologists; MIC, margin ischemia complications; OPN, open partial nephrectomy; PSM, positive
surgical margin; RAPN, robot‐assisted partial nephrectomy; WIT, warm ischaemia time.
F I GUR E 2 Annual overall complication rate of open (grey dots)
and robot‐assisted partial nephrectomies (black crosses). The trend
of annual complication rates in linear regression analysis for OPN
and RAPN is indicated by dashed lines. OPN, open partial
nephrectomy; RAPN, robot‐assisted partial nephrectomy
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